These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 35096475)

  • 21. Agomelatine augmentation of escitalopram therapy in treatment-resistant obsessive-compulsive disorder: a case report.
    De Berardis D; Serroni N; Marini S; Martinotti G; Ferri F; Callista G; La Rovere R; Moschetta FS; Di Giannantonio M
    Case Rep Psychiatry; 2012; 2012():642752. PubMed ID: 23094178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ketamine in treatment-refractory obsessive-compulsive disorder.
    Bloch MH; Wasylink S; Landeros-Weisenberger A; Panza KE; Billingslea E; Leckman JF; Krystal JH; Bhagwagar Z; Sanacora G; Pittenger C
    Biol Psychiatry; 2012 Dec; 72(11):964-70. PubMed ID: 22784486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obsessive-Compulsive Disorder.
    Richter PMA; Ramos RT
    Continuum (Minneap Minn); 2018 Jun; 24(3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY):828-844. PubMed ID: 29851880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of glutamate-related drugs on anxiety and compulsive behavior in rats with obsessive-compulsive disorder.
    Zhan Y; Xia J; Wang X
    Int J Neurosci; 2020 Jun; 130(6):551-560. PubMed ID: 31680595
    [No Abstract]   [Full Text] [Related]  

  • 25. Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder.
    Goodman WK; Storch EA; Sheth SA
    Am J Psychiatry; 2021 Jan; 178(1):17-29. PubMed ID: 33384007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Kvale G; Hansen B; Hagen K; Abramowitz JS; Børtveit T; Craske MG; Franklin ME; Haseth S; Himle JA; Hystad S; Kristensen UB; Launes G; Lund A; Solem S; Öst LG
    JAMA Netw Open; 2020 Aug; 3(8):e2013249. PubMed ID: 32789516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotic treatment in obsessive-compulsive disorder: a literature review.
    Keuneman RJ; Pokos V; Weerasundera R; Castle DJ
    Aust N Z J Psychiatry; 2005 May; 39(5):336-43. PubMed ID: 15860020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suicidality in a 27-year-old Male with Obsessive Compulsive Disorder.
    Ross BM; Lee JD; Espiridion ED
    Cureus; 2018 Dec; 10(12):e3804. PubMed ID: 30868018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice.
    Davis GL; Minerva AR; Lario A; Simmler LD; Rodriguez CI; Gunaydin LA
    Nat Commun; 2021 Oct; 12(1):6040. PubMed ID: 34654803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How willing are you? Willingness as a predictor of change during treatment of adults with obsessive-compulsive disorder.
    Reid AM; Garner LE; Van Kirk N; Gironda C; Krompinger JW; Brennan BP; Mathes BM; Monaghan SC; Tifft ED; André MC; Cattie J; Crosby JM; Elias JA
    Depress Anxiety; 2017 Nov; 34(11):1057-1064. PubMed ID: 28715850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinician-reported barriers to using exposure with response prevention in the treatment of paediatric obsessive-compulsive disorder.
    Keleher J; Jassi A; Krebs G
    J Obsessive Compuls Relat Disord; 2020 Jan; 24():100498. PubMed ID: 32140386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current concepts in the pharmacological treatment of obsessive-compulsive disorder.
    Zohar J; Zohar-Kadouch RC; Kindler S
    Drugs; 1992 Feb; 43(2):210-8. PubMed ID: 1372219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S-ketamine reduces marble burying behaviour: Involvement of ventromedial orbitofrontal cortex and AMPA receptors.
    Tosta CL; Silote GP; Fracalossi MP; Sartim AG; Andreatini R; Joca SRL; Beijamini V
    Neuropharmacology; 2019 Jan; 144():233-243. PubMed ID: 30385254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamatergic augmentation strategies in obsessive-compulsive disorder.
    Sheshachala K; Narayanaswamy JC
    Indian J Psychiatry; 2019 Jan; 61(Suppl 1):S58-S65. PubMed ID: 30745678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder.
    Niciu MJ; Grunschel BD; Corlett PR; Pittenger C; Bloch MH
    J Psychopharmacol; 2013 Jul; 27(7):651-4. PubMed ID: 23676198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial.
    Humble MB; Bejerot S
    Sex Med; 2016 Sep; 4(3):e145-55. PubMed ID: 27320409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ziprasidone Augmentation in an Adolescent with Obsessive Compulsive Disorder: A Case Report.
    Demirkaya SK; Alyanak B
    Psychopharmacol Bull; 2016 Mar; 46(1):73-76. PubMed ID: 27738375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Avoidance-Based Rodent Model of Exposure With Response Prevention Therapy for Obsessive-Compulsive Disorder.
    Rodriguez-Romaguera J; Greenberg BD; Rasmussen SA; Quirk GJ
    Biol Psychiatry; 2016 Oct; 80(7):534-40. PubMed ID: 27086546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of the role of serotonin system genes in obsessive-compulsive disorder.
    Sinopoli VM; Burton CL; Kronenberg S; Arnold PD
    Neurosci Biobehav Rev; 2017 Sep; 80():372-381. PubMed ID: 28576508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.